Maze Therapeutics, Inc. (MAZE)
44.22
-0.82
(-1.82%)
USD |
NASDAQ |
Feb 20, 16:00
44.10
-0.12
(-0.27%)
After-Hours: 06:08
Maze Therapeutics SG&A Expense (Quarterly) : 7.775M for Sept. 30, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| CDT Equity, Inc. | 5.501M |
| LENZ Therapeutics, Inc. | 27.60M |
| Liminatus Pharma, Inc. | 0.7012M |
| Oruka Therapeutics, Inc. | 5.117M |
| MapLight Therapeutics, Inc. | 4.404M |